AlphaQuest’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,761
Closed -$376K 125
2025
Q4
$376K Sell
7,761
-1,282
-14% -$50K 0.02% 1040
2025
Q3
$277K Buy
+9,043
New +$208K 0.02% 1213
2025
Q2
Sell
-4,220
Closed -$78.5K 2041
2025
Q1
$78.5K Sell
4,220
-241
-5% -$4.02K 0.01% 1395
2024
Q4
$59.1K Buy
4,461
+4,237
+1,892% +$103K 0.01% 1253
2024
Q3
$7.5K Buy
+224
New +$7.65K ﹤0.01% 1564
2024
Q2
Sell
-586
Closed -$13.2K 1568
2024
Q1
$13.2K Sell
586
-4,987
-89% -$118K ﹤0.01% 1063
2023
Q4
$119K Buy
+5,573
New +$96.1K 0.03% 731

Other funds holding ANAB

AlphaQuest's ANAB Position: Q1 2026 in Review

AlphaQuest sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 7,761 shares — an estimated $376K sold.

AlphaQuest first reported a position in ANAB in Q4 2023 and held it in 7 quarters. The position peaked at $376K in Q4 2025. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • AlphaQuest reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 7,761 AnaptysBio shares in Q1 2026, an estimated $376K.
  • AlphaQuest first reported a position in AnaptysBio in Q4 2023 and held it in 7 quarters.
  • AlphaQuest's AnaptysBio position peaked at $376K in Q4 2025.
  • 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.